Exhibit 99.2

Unaudited Interim Condensed Consolidated Statement of Profit or Loss

for the six-month periods ended June 30, 2019 and 2018

amounts in thousands except per share amounts

	Six-Month Periods Ended June 30,
	2019			2018
	USD			USD
Research and development costs		(626	)		(1,843	)
General and administrative costs		(2,602	)		(5,803	)
Operating loss		(3,228	)		(7,646	)
Foreign exchange rate gain		187			1,859
Other finance income		191			313
Loss before taxes		(2,850	)		(5,474	)
Income tax benefit		—			204
Net loss for the period		(2,850	)		(5,270	)
Net loss for the period attributable to:
Equity holders of the Parent		(2,850	)		(5,270	)
Per share amounts:
Net loss per share basic and diluted		(0.03	)		(0.06	)

5